chrX-70063125-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_207320.3(OTUD6A):c.601G>A(p.Asp201Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,209,502 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_207320.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTUD6A | NM_207320.3 | c.601G>A | p.Asp201Asn | missense_variant | 1/1 | ENST00000338352.3 | NP_997203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTUD6A | ENST00000338352.3 | c.601G>A | p.Asp201Asn | missense_variant | 1/1 | 6 | NM_207320.3 | ENSP00000339389.2 |
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111601Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33807
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182676Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67314
GnomAD4 exome AF: 0.0000118 AC: 13AN: 1097901Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 7AN XY: 363321
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111601Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33807
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.601G>A (p.D201N) alteration is located in exon 1 (coding exon 1) of the OTUD6A gene. This alteration results from a G to A substitution at nucleotide position 601, causing the aspartic acid (D) at amino acid position 201 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at